Cue Biopharma logo
Cue Biopharma CUE
€ 0.20 -0.99%

Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025

report update icon

Cue Biopharma Langfristiger Schuldenstrom 2011-2025 | CUE

Langfristiger Schuldenstrom Jährlich Cue Biopharma

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.54 M 3.37 M 3.3 M 4.93 M 4.78 M 4.45 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
4.93 M 3.3 M 4.06 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
425 K $ 4.79 2.35 % $ 795 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
481 K $ 3.04 4.83 % $ 235 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
BioVie BioVie
BIVI
74.5 K $ 1.27 -3.05 % $ 1.88 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 1.17 4.46 % $ 6.38 M chinaChina
Aptevo Therapeutics Aptevo Therapeutics
APVO
800 K $ 0.93 -8.81 % $ 257 K usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
17.6 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
11 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
3.29 M - -7.31 % $ 87 M usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 212.81 1.71 % $ 5 B danmarkDanmark
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 0.18 -25.03 % $ 392 M israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
210 K $ 12.37 2.06 % $ 814 M usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
3.4 M - - $ 7.29 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.1 0.16 % $ 7.46 B australiaAustralia
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
Celsion Corporation Celsion Corporation
CLSN
452 K - -6.63 % $ 13.9 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 95.03 0.95 % $ 27.2 B germanyGermany
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
829 K $ 83.59 1.95 % $ 8.63 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
402 K $ 24.45 0.91 % $ 2.9 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
6.8 M $ 26.81 1.36 % $ 1.3 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 9.48 0.96 % $ 139 M usaUSA
Cortexyme Cortexyme
CRTX
64 K - -1.05 % $ 67.1 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
781 K - - $ 1.2 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Axon Enterprise Axon Enterprise
AXON
9.45 M $ 591.15 0.02 % $ 44.8 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.53 -0.39 % $ 15.9 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
339 M $ 92.45 0.34 % $ 96.9 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
1.45 M $ 26.83 0.94 % $ 1.73 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA